BetterLife Pharma Announces Engagement with Shanghai-Based YAFO Capital
Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biotech company focused on development of BETR-001, its proprietary non-hallucinogenic derivative of lysergic acid diethylamide ("LSD"), is pleased to announce it has signed an engagement agreement with Shanghai-based YAFO Capital ("YAFO"), as its exclusive advisor to seek strategic partnerships for development of BETR-001 in the Greater China regions, including mainland China, Hong Kong, Taiwan and Macau. Pursuant to...
2025-12-11 8:00 AM EST
Pivot Pharma Retains Cannabis Compliance to File Dealer's License Application on Behalf of Agro-Biotech Inc.
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) ("Pivot" or the "Company"), is pleased to announce that the Company has retained Cannabis Compliance Inc. ("CCI") to submit an application to Health Canada for a Dealer's License ("Dealer's License" or "DL") under the Controlled Drugs and Substances Act ("CDSA") and the Narcotic Control Regulations enacted thereunder on behalf of Agro-Biotech Inc. ("Agro-Biotech"). As previously anno
2018-03-12 3:30 AM EDT
Pivot Pharma Acquires Thrudermic, LLC
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce the acquisition of Thrudermic, LLC ("TDL" or "Thrudermic"), a privately held North Carolina company. Pivot previously announced a licensing agreement with Thrudermic but has decided to exercise its option to acquire 100% of TDL. Pivot will pay $1.00 (USD) for all of the issued and outstanding units of Thrudermic, and issue an aggregate of 500,000 common...
2018-03-06 9:13 AM EST
Pivot Pharma Closes C$5M Private Placement of Convertible Debentures
Vancouver, British Columbia--(Newsfile Corp. - March 5, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce the closing of its previously announced private placement of convertible debentures for aggregate gross proceeds of C$5 million (the "Offering"). The Company intends to use the net proceeds of the Offering for the development of its pipeline of products, intellectual property acquisitions, and for working capital and general corporate purposes.Pursuant to the Offering, the Company issued...
2018-03-05 8:00 AM EST
Pivot Pharma Completes Acquisition of California-Based ERS Holdings, LLC
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), is pleased to announce that the Company has completed the acquisition of ERS Holdings, LLC ("ERS"), a privately-held California company. As previously announced on December 20, 2017, ERS has developed a patented technology called "RTIC" Ready-To-Infuse-Cannabis (the "Patent"), relating to the transformation of cannabis oil into powder for infusion into a variety of food and beverage p
2018-02-27 9:27 AM EST
Pivot Pharma Announces Letter of Intent for Proposed Acquisition of Agro-Biotech, a Québec-based ACMPR Licensed Producer
Vancouver, British Columbia--(Newsfile Corp. - February 22, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce that it has entered into an arm's-length non-binding letter of intent (the "LOI") pursuant to which Pivot proposes to acquire (the "Proposed Transaction") Agro-Biotech Inc. ("Agro-Biotech"), a Health Canada ACMPR Licensed Producer located in Saint-Eustache, Québec. Following the completion of the Proposed Transaction, which is anticipated to occur by April 15, 2018, Agro-Biotech will continue to operate...
2018-02-22 5:44 PM EST
Pivot Provides Market Activity Update
Vancouver, British Columbia--(Newsfile Corp. - February 13, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), a biopharmaceutical company engaged in the development and commercialization of cannabinoid-based therapeutics using innovative drug formulation and delivery platform technologies, wishes to to address the recent decline in its share price. There has been no material change to Pivot's business plan that would justify the market decline. Pivot continues to successfully execute on its business strategy. Product development is advancing...
2018-02-13 3:29 PM EST
Pivot Pharmaceuticals Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - February 12, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), a biopharmaceutical company engaged in the development and commercialization of cannabinoid-based therapeutics using innovative drug formulation and delivery platform technologies, is pleased to provide its shareholders with the following Corporate Update.Pivot has had a very active start to 2018 as the management team continues to build a "differentiated" company in the cannabis sector, focusing on improving the cannabis consumer experience...
2018-02-12 4:00 AM EST
Pivot Files Three New Provisional Patents for the Delivery of Cannabinoids
Vancouver, British Columbia--(Newsfile Corp. - February 1, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), is pleased to announce that it has filed three provisional patents with the United States Patent and Trademark Office ("USPTO") related to the delivery of cannabinoid-based products. The applications cover the following areas:Transdermal nanotechnology delivery system of cannabis using patches and creams;Mucus topical cannabis delivery system through buccal, nasal, vaginal and anal areas of entry using a gel, suppository or...
2018-02-01 4:00 AM EST
Pivot Continues To Build Technology Portfolio
Vancouver, British Columbia--(Newsfile Corp. - January 17, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), and its wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. ("PGS" or "Pivot Green Stream"), are pleased to provide its shareholders with a Corporate Update.Since Pivot's entry into the cannabis industry, we have accumulated the following four patented or proprietary technologies to deliver cannabinoids into the human body that avoid exposure to carcinogens from smoking:
2018-01-17 4:00 AM EST
Pivot To Initiate Topical Product Development With Israel Based Research Organizations
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), and its wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. ("PGS" or "Pivot Green Stream"), are pleased to announce that the Company has signed a Service Agreement with SoluBest Ltd., an Israeli-based research organization that specializes in the development of client tailored formulation and pilot production services and scale-up. SoluBest, located near the prestigious Weizmann Inst
2018-01-09 7:00 AM EST
Pivot to Commercialize Cannabis Products in California Under New Regulations
Vancouver, British Columbia--(Newsfile Corp. - January 3, 2018) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce that its recent Binding Letter of Intent to acquire ERS Holdings LLC's patent for Ready To Infuse Cannabis Technology (RTIC) for food and beverage-based products will permit the company to commercialize K-Cup and Stick Pack cannabis products under the new regulations that took effect in California on January 1st, 2018. Pivot will initiate development of...
2018-01-03 4:00 AM EST
Pivot Enters Into Standstill Agreement
Vancouver, British Columbia--(Newsfile Corp. - December 27, 2017) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company") wishes to announce that it has entered into a forty-five (45) day standstill period with a TSX listed company in order to explore a business opportunity of mutual interest and benefit, that may result in a co-research and development program, a product launch and/or commercialization agreement, or some other form of potential partnership ("Potential Transaction").The standstill period will end on...
2017-12-27 4:00 AM EST
Pivot to Enter Legal Cannabis Markets in U.S.
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2017) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), and its wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. ("PGS" or "Pivot Green Stream"), are pleased to announce that Pivot has signed a binding letter of intent to establish a California-based entity ("PGS-California") in order to accelerate the monetization of the Ready To Infuse Cannabis ("RTIC") technology as previously announced on December 20, 2017. Pivot plans...
2017-12-22 9:25 AM EST
Pivot Pharma Signs Binding Letter of Intent to Acquire Cannabis Oil Infusion Technology for Use in Food and Beverage Products
Vancouver, British Columbia--(Newsfile Corp. - December 20, 2017) - Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) ("Pivot" or the "Company"), an emerging biopharmaceutical company, is pleased to announce that the Company has signed a Binding Letter of Intent to acquire ERS Holdings, LLC ("ERS"), a privately-held California company. ERS has developed a patented technology called "RTIC" - Ready To Infuse Cannabis ("the Patent") and has also filed several continuation patents relating to the transformation of cannabis oil into powder for...
2017-12-20 4:00 AM EST